These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 34379444)

  • 1. COVID-19 and Diabetes.
    Singh AK; Khunti K
    Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
    Singh AK; Khunti K
    Diabetes Res Clin Pract; 2020 Jul; 165():108266. PubMed ID: 32533989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.
    Goyal A; Gupta Y; Kalaivani M; Praveen PA; Ambekar S; Tandon N
    Endocr Pract; 2022 Feb; 28(2):191-198. PubMed ID: 34920109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Dubey R; Prabhakar PK; Batiha GE
    Curr Mol Pharmacol; 2023; 16(4):494-506. PubMed ID: 36089790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.
    Stoian AP; Papanas N; Prazny M; Rizvi AA; Rizzo M
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):494-496. PubMed ID: 32618198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of Type 2 Diabetes on Disease Severity, Therapeutic Effect, and Mortality of Patients With COVID-19.
    Wang X; Liu Z; Li J; Zhang J; Tian S; Lu S; Qi M; Ma J; Qiu B; Dong W; Xu Y
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32979271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease 2019 and type 1 diabetes mellitus.
    Chang DJ; Moin T
    Curr Opin Endocrinol Diabetes Obes; 2021 Feb; 28(1):35-42. PubMed ID: 33278126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence.
    Sen S; Chakraborty R; Kalita P; Pathak MP
    World J Clin Cases; 2021 Oct; 9(28):8327-8339. PubMed ID: 34754842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New onset diabetes, type 1 diabetes and COVID-19.
    Boddu SK; Aurangabadkar G; Kuchay MS
    Diabetes Metab Syndr; 2020; 14(6):2211-2217. PubMed ID: 33395782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
    Jagat J M; Kalyan K G; Subir R
    Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail.
    Pal R; Bhasin MK; Bhadada SK
    Infect Disord Drug Targets; 2021; 21(5):e270421186842. PubMed ID: 33050869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.
    Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1777-1781. PubMed ID: 32942253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPP-4 inhibition and COVID-19: From initial concerns to recent expectations.
    Scheen AJ
    Diabetes Metab; 2021 Mar; 47(2):101213. PubMed ID: 33249199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19.
    Xu Z; Wang Z; Wang S; Ye Y; Luo D; Wan L; Yu A; Sun L; Tesfaye S; Meng Q; Gao L
    J Diabetes; 2020 Dec; 12(12):909-918. PubMed ID: 32638507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.